Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Clinical trial NCT06855745 · RECRUITING

Trial details

NCT number: NCT06855745
Sponsor: Alphyn Biologics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis (Eczema)Atopic Dermatitis Eczema Atopic Dermatitis Atopic Dermatitis (AD)Eczema Eczema, Atopic

Start date: 2025-03-25
Primary completion: 2025-10-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.